| NCT ID | NCT06785129 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Migraine |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-02-12 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-02-12 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.
Eligibility Criteria
Inclusion Criteria: 1. Patients with diagnosed endometriosis, migraine, or both endometriosis and migraine 2. Healthy control subjects with no history of chronic pain 3. Age 12-45 4. Assigned female sex at birth Exclusion Criteria: 1. Pregnancy or breastfeeding 2. Presence of prolactinoma 3. Presence of psychiatric, neurological, endocrinological and/or developmental conditions and taking medications for these conditions 4. Current use of dopamine agonist or SSRI medications 5. For patients aged 12-17 not having a parent/legal guardian willing to sign the consent and answer surveys about their child's health
Contact & Investigator
Hadas Nahman-Averbuch, PhD
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT06785129 clinical trial?
This trial is open to female participants only, aged 12 Years or older, up to 45 Years, studying Migraine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06785129 currently recruiting?
Yes, NCT06785129 is actively recruiting participants. Contact the research team at painlab@wustl.edu for enrollment information.
Where is the NCT06785129 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT06785129 clinical trial?
NCT06785129 is sponsored by Washington University School of Medicine. The principal investigator is Hadas Nahman-Averbuch, PhD at Washington University School of Medicine. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.